amsacrine has been researched along with Seizures in 2 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mittelman, A | 1 |
| Arlin, ZA | 1 |
| Harvey, VJ | 1 |
| Hardy, JR | 1 |
| Smith, S | 1 |
| Grove, W | 1 |
| Baguley, BC | 1 |
2 other studies available for amsacrine and Seizures
| Article | Year |
|---|---|
AMSA-induced seizures in patients with hypokalemia.
Topics: Aminoacridines; Amsacrine; Female; Humans; Hypokalemia; Leukemia; Middle Aged; Seizures | 1983 |
Phase II study of the amsacrine analogue CI-921 (NSC 343499) in non-small cell lung cancer.
Topics: Adult; Aged; Amsacrine; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Fema | 1991 |